Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Paul Chan, Li Shao, Brian Tomlinson, Yuzhen Zhang & Zhong-Min Liu. (2019) An evaluation of pitavastatin for the treatment of hypercholesterolemia. Expert Opinion on Pharmacotherapy 20:1, pages 103-113.
Read now
Read now
T. D. Filippatos & M. S. Elisaf. (2016) Pitavastatin and carbohydrate metabolism: what is the evidence?. Expert Review of Clinical Pharmacology 9:7, pages 955-960.
Read now
Read now
Aris P Agouridis, Michael S Kostapanos & Moses S Elisaf. (2015) Statins and their increased risk of inducing diabetes. Expert Opinion on Drug Safety 14:12, pages 1835-1844.
Read now
Read now
Articles from other publishers (30)
Bahar Arican Tarim, Francesco Fici, Istemihan Tengiz, Saadet Avunduk, Yurdaer Ozcan, Gokhan Faikoglu, Elif Ari, Nicolás Roberto Robles & Guido Grassi. (2023) Do Statins Counteract the Effect of Antidiabetic Drugs? Results of the SCEAD Study. Yonsei Medical Journal 64:3, pages 175.
Crossref
Crossref
Jeongmin Lee, Min-Hee Kim, Jung-Min Lee & Sang-Ah Chang. (2022) Does Pitavastatin Therapy for Patients with Type 2 Diabetes and Dyslipidemia Affect Serum Adiponectin Levels and Insulin Sensitivity?. Journal of Clinical Medicine 11:22, pages 6756.
Crossref
Crossref
Nasreen Alsayed, Wael Almahmeed, Fahad Alnouri, Khalid Al-Waili, Hani Sabbour, Kadhim Sulaiman, Mohammad Zubaid, Kausik K. Ray & Khalid Al-Rasadi. (2022) Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update. Atherosclerosis 343, pages 28-50.
Crossref
Crossref
Toralf Bruning & Mohamed Al-Khaled. (2021) Do statins reduce the mortality rate in stroke patients treated with systemic thrombolysis in a 5-year. Neural Regeneration Research 16:9, pages 1807.
Crossref
Crossref
Hae-Young Lee, Ki-Hoon Han, Woo-Baek Chung, Sung-Ho Her, Tae-Ho Park, Seung-Woon Rha, So-Yeon Choi, Kyung-Tae Jung, Jong-Seon Park, Pum-Joon Kim, Jong-Min Lee, Myung-Ho Jeong, Eun-Seok Shin, Hyeon-Cheol Gwon, Kyoo-Rok Han, Jei-Keon Chae, Woo-Shik Kim, Dong-Ju Choi, Bum-Kee Hong, Si-Wan Choi & Namsik Chung. (2020) Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia: A Randomized, Open-labeled, Multicentered, Phase IV Study. Clinical Therapeutics 42:10, pages 2036-2048.
Crossref
Crossref
M. John Chapman, Alexina Orsoni, Ricardo Tan, Natalie A. Mellett, Anh Nguyen, Paul Robillard, Philippe Giral, Patrice Thérond & Peter J. Meikle. (2020) LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL. Journal of Lipid Research 61:6, pages 911-932.
Crossref
Crossref
Mohamed Anwar Hammad, Mahmoud Saeed Abdo, Abdalla Mohamed Mashaly, Syed Azhar Syed Sulaiman, Saleh Alghamdi, Altaf A. Mangi & Dzul Azri Mohamed Noor. (2019) The statins effects on HbA1c control among diabetic patients: An umbrella review of systematic reviews and meta-analyses of observational studies and clinical trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:4, pages 2557-2564.
Crossref
Crossref
Swati Kaushik, Ameesha Tomar, Susrutha Puthanmadhom Narayanan, Tapas Chandra Nag, Dharamvir Singh Arya & Jagriti Bhatia. (2019) Pitavastatin attenuates cisplatin-induced renal injury by targeting MAPK and apoptotic pathways. Journal of Pharmacy and Pharmacology 71:7, pages 1072-1081.
Crossref
Crossref
Laurie R Braun, Meghan N Feldpausch, Natalia Czerwonka, Julian Weiss, Karen Branch, Hang Lee, Edgar L Martinez-Salazar, Martin Torriani, Craig A Sponseller, Steven K Grinspoon & Takara L Stanley. (2018) Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism 103:11, pages 4176-4186.
Crossref
Crossref
Jah Yeon Choi, Cheol Ung Choi, Soon-Young Hwang, Byoung Geol Choi, Won Young Jang, Do Young Kim, Woohyeun Kim, Eun Jin Park, Sunki Lee, Jin Oh Na, Jin Won Kim, Eung Ju Kim, Seung-Woon Rha, Chang Gyu Park, Hong Seog Seo, Sung-Chull Chae, Young Jo Kim, Myeong Chan Cho, Chong Jin Kim, Hyo-Soo Kim & Myung Ho Jeong. (2018) Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction. The American Journal of Cardiology 122:6, pages 922-928.
Crossref
Crossref
M. John Chapman, Alexina Orsoni, Paul Robillard, Patrice Therond & Philippe Giral. (2018) Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP. Journal of Clinical Lipidology 12:3, pages 784-800.e4.
Crossref
Crossref
Jun-Bean Park, Ji-Hyun Jung, Yeonyee E. Yoon, Hack-Lyong Kim, Seung-Pyo Lee, Hyung-Kwan Kim, Yong-Jin Kim, Goo-Yeong Cho & Dae-Won Sohn. (2017) Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial. Trials 18:1.
Crossref
Crossref
Uchenna Anyanwagu, Jil Mamza, Richard Donnelly & Iskandar Idris. (2017) Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study. Cardiovascular Diabetology 16:1.
Crossref
Crossref
Angela Pirillo & Alberico L. Catapano. (2017) Pitavastatin and HDL: Effects on plasma levels and function(s). Atherosclerosis Supplements 27, pages e1-e9.
Crossref
Crossref
M. Casula, F. Mozzanica, L. Scotti, E. Tragni, A. Pirillo, G. Corrao & A.L. Catapano. (2017) Statin use and risk of new-onset diabetes: A meta-analysis of observational studies. Nutrition, Metabolism and Cardiovascular Diseases 27:5, pages 396-406.
Crossref
Crossref
Sheridan M. Hoy. (2017) Pitavastatin: A Review in Hypercholesterolemia. American Journal of Cardiovascular Drugs 17:2, pages 157-168.
Crossref
Crossref
Alexina Orsoni, Patrice Thérond, Ricardo Tan, Philippe Giral, Paul Robillard, Anatol Kontush, Peter J. Meikle & M. John Chapman. (2016) Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia. Journal of Lipid Research 57:11, pages 2073-2087.
Crossref
Crossref
Niki Katsiki & Christos S. Mantzoros. (2016) Statins in relation to adiponectin: A significant association with clinical implications. Atherosclerosis 253, pages 270-272.
Crossref
Crossref
Piotr Chruściel, Amirhossein Sahebkar, Magdalena Rembek-Wieliczko, Maria-Corina Serban, Sorin Ursoniu, Dimitri P. Mikhailidis, Steven R. Jones, Svetlana Mosteoru, Michael J. Blaha, Seth S. Martin, Jacek Rysz, Peter P. Toth, Gregory Y.H. Lip, Michael J. Pencina, Kausik K. Ray & Maciej Banach. (2016) Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis 253, pages 194-208.
Crossref
Crossref
Vivencio Barrios & Carlos Escobar. (2016) Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes. Future Cardiology 12:4, pages 449-466.
Crossref
Crossref
D. John Betteridge & Rafael Carmena. (2015) The diabetogenic action of statins — mechanisms and clinical implications. Nature Reviews Endocrinology 12:2, pages 99-110.
Crossref
Crossref
Peter J. Meikle, Gerard Wong, Ricardo Tan, Philippe Giral, Paul Robillard, Alexina Orsoni, Neil Hounslow, Dianna J. Magliano, Jonathan E. Shaw, Joanne E. Curran, John Blangero, Bronwyn A. Kingwell & M.John Chapman. (2015) Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia. Journal of Lipid Research 56:12, pages 2381-2392.
Crossref
Crossref
Joan Rius Tarruella, Jesús Millán Núñez-Cortés, Juan Pedro-Botet & Xavier Pintó Sala. (2015) La diabetogenicidad de las estatinas: ¿son todas iguales? Estado de la cuestión. Clínica e Investigación en Arteriosclerosis 27:3, pages 148-158.
Crossref
Crossref
Niki Katsiki, Manfredi Rizzo, Dimitri P. Mikhailidis & Christos S. Mantzoros. (2015) New-Onset Diabetes and Statins: Throw the Bath Water Out, But, Please, Keep the Baby!. Metabolism 64:4, pages 471-475.
Crossref
Crossref
Wei Cheng YuetHtet KhineZahid Ahmad. (2015) Statin-Associated Adverse Events. Clinical Medicine Insights: Therapeutics 7, pages CMT.S18865.
Crossref
Crossref
Lorenzo Arnaboldi & Alberto Corsini. (2015) Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin. Atherosclerosis Supplements 16, pages 1-27.
Crossref
Crossref
Alexander Tenenbaum, Robert Klempfner & Enrique Z Fisman. (2014) Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovascular Diabetology 13:1.
Crossref
Crossref
Sebhat Erqou, C. Christine Lee & Amanda I. Adler. (2014) Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis. Diabetologia 57:12, pages 2444-2452.
Crossref
Crossref
Naveed A. Sattar, Henry Ginsberg, Kausik Ray, M. John Chapman, Marcello Arca, Maurizio Averna, D. John Betteridge, Deepak Bhatnagar, Elena Bilianou, Rafael Carmena, Richard Češka, Alberto Corsini, Raimund Erbel, Paul D. Flynn, Xavier Garcia-Moll, Janusz Gumprecht, Shun Ishibashi, Selim Jambart, John J.P. Kastelein, Vincent Maher, Pedro Marques da Silva, Luis Masana, Masato Odawara, Terje R. Pedersen, Carlo Maria Rotella, Ibrahim Salti, Tamio Teramoto, Lale Tokgozoglu, Peter P. Toth, Paul Valensi & Bruno Vergès. (2014) The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice. Atherosclerosis Supplements 15:1, pages 1-15.
Crossref
Crossref
Soo Lim & Philip Barter. (2014) Antioxidant Effects of Statins in the Management of Cardiometabolic Disorders. Journal of Atherosclerosis and Thrombosis 21:10, pages 997-1010.
Crossref
Crossref